Glycerophospholipids for the improvement of cognitive functions
AssigneeEnzyomtec Ltd.
InventorsGai Ben Dror, Dorit Platt, Orly Farkash, Rassan Zuabi, Zohar Bar-On, Avidor Shulman, Dori Pelled, Yael Richter
Life of this patent
Estimating the term…
Abstract
The invention described herein provides a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates with a specific content and specific conjugation patterns of LA, linolenic acid (alpha-linolenic acid, gamma-linolenic acid) DHA and EPA which depend on utilizing different sources of lipids, and uses of such preparations.
Claims8
A method of improving a condition in a subject suffering from Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, or concentration and attention impairment, which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, wherein the mixture comprises (a) linoleic acid (C18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (c) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w % of (a)/the w/w % of (b) is from about 0.09 to about 3.6 and the w/w % of (a)/w/w % of (c) is from about 0.23 to about 9.4, so as to thereby improve the Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, or concentration and attention impairment in the subject.
Dependencies are inferred from the claim text.